BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Muvalaplin readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Muvalaplin\, from ClinicalTrials.gov esti
 mates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07157774-1042@assetmemo.bio
DTSTAMP:20261121T004050Z
DTSTART;VALUE=DATE:20310331
DTEND;VALUE=DATE:20310401
SUMMARY:Muvalaplin: Phase 3 readout est. (NCT07157774)
DESCRIPTION:Muvalaplin\, phase 3\, Atherosclerotic Cardiovascular Disease.\
 nStudy: Assessing the Impact of Muvalaplin on Major Cardiovascular Events 
 in Adults With Elevated Lipoprotein(a)\nEstimated primary completion: Marc
 h 2031. This is a ClinicalTrials.gov estimate\, not a confirmed readout da
 te\, and it can move.\nDrug page: https://assetmemo.bio/drug/muvalaplin#up
 coming-events\nRegistry record: https://clinicaltrials.gov/study/NCT071577
 74
URL:https://assetmemo.bio/drug/muvalaplin#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
